Analyzing Ratios: Sagimet Biosciences Inc (SGMT)’s Financial Story Unveiled

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The price of Sagimet Biosciences Inc (NASDAQ: SGMT) closed at $4.88 in the last session, up 3.83% from day before closing price of $4.70. In other words, the price has increased by $3.83 from its previous closing price. On the day, 1.05 million shares were traded. SGMT stock price reached its highest trading level at $4.92 during the session, while it also had its lowest trading level at $4.46.


We take a closer look at SGMT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 43.12 and its Current Ratio is at 43.12. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on May 02, 2024, initiated with a Buy rating and assigned the stock a target price of $32.

On March 25, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $26.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 26 ’24 when Happel David bought 12,100 shares for $5.27 per share. The transaction valued at 63,731 led to the insider holds 639,200 shares of the business.

Happel David bought 1,600 shares of SGMT for $6,560 on Dec 07 ’23. The President & CEO now owns 627,100 shares after completing the transaction at $4.10 per share. On Nov 16 ’23, another insider, Happel David, who serves as the President & CEO of the company, bought 590 shares for $2.35 each. As a result, the insider paid 1,386 and bolstered with 590 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMT now has a Market Capitalization of 155739840 and an Enterprise Value of -37939232. For the stock, the TTM Price-to-Sale (P/S) ratio is 77.86 while its Price-to-Book (P/B) ratio in mrq is 0.82. Its current Enterprise Value per Revenue stands at -18.97.

Stock Price History:

Over the past 52 weeks, SGMT has reached a high of $20.71, while it has fallen to a 52-week low of $2.13. The 50-Day Moving Average of the stock is 4.05%, while the 200-Day Moving Average is calculated to be -23.00%.

Shares Statistics:

According to the various share statistics, SGMT traded on average about 692.16K shares per day over the past 3-months and 708820 shares per day over the past 10 days. A total of 21.38M shares are outstanding, with a floating share count of 20.79M. Insiders hold about 34.84% of the company’s shares, while institutions hold 59.79% stake in the company. Shares short for SGMT as of 1715731200 were 2139266 with a Short Ratio of 3.09, compared to 1713139200 on 2068294. Therefore, it implies a Short% of Shares Outstanding of 2139266 and a Short% of Float of 8.02.

Most Popular